HIV/INFECTIOUS DISEASE TEST/TREATMENT IN SUBSTANCE ABUSE

描述：（申请人摘要） 拟议项目的第一阶段将审查全面防治艾滋病毒的障碍， 药物滥用者的其他传染病检测和后续护理 短期（戒毒）药物滥用治疗中心。在第二阶段， 包括全面检测、咨询、医疗延期、 克服后续护理障碍的实用战略将是 设计和试点测试。在第三阶段，将对干预措施进行评估 与通过随机抽样提供艾滋病毒检测的护理标准相比， 对照试验将对344名受试者进行随机分组 接受全面检测和便利转诊 提供艾滋病毒、B型和C型肝炎以及性病检测的干预措施 淋病和衣原体（和滴虫，仅限女性）或标准治疗 单独进行艾滋病毒检测，并转诊进行进一步的肝炎和性病检测。初级 终点将是执行的测试数量、测试结果数量 接受的治疗，以及两组获得的随访医疗护理程度。

DESCRIPTION: (Applicant's Abstract) Phase I of the proposed project will examine barriers to comprehensive HIV and other infectious disease testing and follow-up care among substance abusers at a short term (detox) substance abuse treatment center. In Phase II an intervention that includes comprehensive testing, counseling, medical deferral, and practical strategies to overcome barriers to follow up care will be designed and pilot tested. During Phase III, the intervention will be evaluated against the standard of care of offering HIV testing done through a randomized controlled trial. Three hundred and forty-four participants will be randomized to receive either the comprehensive testing and facilitated referral intervention which will offer testing for HIV, hepatitis B and C, and the STDs gonorrhea and chlamydia (and trichomonas for women only) or standard of care HIV testing alone and referral for further hepatitis and STD testing. Primary endpoints will be the number of tests performed, the number of test results received, and the degree of follow up medical care obtained for the two groups.